Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$55.32 - $67.54 $12.5 Million - $15.2 Million
225,751 Added 12.75%
1,996,066 $119 Million
Q2 2022

Aug 15, 2022

SELL
$53.08 - $81.37 $6.94 Million - $10.6 Million
-130,799 Reduced 6.88%
1,770,315 $99.4 Million
Q4 2021

Feb 14, 2022

SELL
$62.62 - $79.92 $3.61 Million - $4.61 Million
-57,693 Reduced 2.95%
1,901,114 $137 Million
Q3 2021

Nov 15, 2021

SELL
$76.41 - $84.06 $7.22 Million - $7.94 Million
-94,427 Reduced 4.6%
1,958,807 $150 Million
Q1 2021

May 14, 2021

BUY
$60.05 - $67.74 $8.2 Million - $9.26 Million
136,634 Added 7.13%
2,053,234 $127 Million
Q4 2020

Feb 12, 2021

BUY
$48.89 - $65.87 $34.4 Million - $46.3 Million
703,400 Added 57.98%
1,916,600 $125 Million
Q3 2020

Nov 13, 2020

SELL
$45.26 - $57.82 $10.4 Million - $13.3 Million
-229,300 Reduced 15.9%
1,213,200 $60.1 Million
Q2 2020

Aug 14, 2020

BUY
$39.81 - $55.61 $16.6 Million - $23.2 Million
417,250 Added 40.7%
1,442,500 $68.8 Million
Q1 2020

May 15, 2020

BUY
$35.06 - $59.45 $35.9 Million - $61 Million
1,025,250 New
1,025,250 $43.6 Million

Others Institutions Holding GMED

About GLOBUS MEDICAL INC


  • Ticker GMED
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 77,037,200
  • Market Cap $6.25B
  • Description
  • Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...
More about GMED
Track This Portfolio

Track Capital Research Global Investors Portfolio

Follow Capital Research Global Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.